Loading...

SRPT SAREPTA THERAPEUTICS INC Capital Structure Changes 8-K Filing

SRPT

SRPT

SAREPTA THERAPEUTICS INC

(SRPT)

2024 8-K

Show Summary

Show Summary

Rights Offerings

Earnings Announcement

Credit Agreement

Financial Results

Collaboration Agreement

Amendment to Incentive Plan

Financial Results

FDA Approval of ELEVIDYS

Annual Meeting Results

External Links:

Sarepta Therapeutics, Inc. approved an amendment to their Employment Commencement Incentive Plan to increase the maximum number of shares available for issuance by 500,000 shares.

AI Assistant

SAREPTA THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.